Saturn Partners

Saturn Partners is a Boston-based venture capital firm that invests in seed and early-stage technology companies. Founded in 1994, the firm pursues opportunities in information technology and financial technology and has expanded to sectors such as advanced materials, specialty energy, electronic commerce, digital media, life sciences, and telecommunications. Saturn Partners emphasizes hands-on involvement, partnering with entrepreneurs to provide capital and operational expertise rather than participating only in quarterly board discussions. Initial investments typically range from $1 million to $3 million, with reserves structured to support future growth. The firm has arranged equity financing of over $100 million for more than 20 emerging companies, reflecting a track record of supporting rapid early-stage growth.

William Guttman

General Partner

Edward Lafferty

General Partner and CFO

Jeffrey McCormick

Founder, Managing Partner

24 past transactions

Areteia Therapeutics

Series A in 2024
Areteia Therapeutics is a biotechnology company focused on developing oral therapies for eosinophilic asthma to improve disease control. The company was spun out of Knopp and is advancing an oral drug designed to inhibit eosinophil maturation, aiming to reduce inflammation and alleviate symptoms of severe asthma. Phase 2 data from its program indicated the oral candidate lowers blood eosinophil counts, a marker associated with better lung function. By pursuing an oral, non-injectable treatment option, Areteia seeks to offer a convenient alternative to injectable therapies and broaden access for asthma patients. The company’s work centers on targeting eosinophil-related pathways to enhance asthma management and patient quality of life.

Areteia Therapeutics

Series A in 2022
Areteia Therapeutics is a biotechnology company focused on developing oral therapies for eosinophilic asthma to improve disease control. The company was spun out of Knopp and is advancing an oral drug designed to inhibit eosinophil maturation, aiming to reduce inflammation and alleviate symptoms of severe asthma. Phase 2 data from its program indicated the oral candidate lowers blood eosinophil counts, a marker associated with better lung function. By pursuing an oral, non-injectable treatment option, Areteia seeks to offer a convenient alternative to injectable therapies and broaden access for asthma patients. The company’s work centers on targeting eosinophil-related pathways to enhance asthma management and patient quality of life.

Third Pole Therapeutics

Venture Round in 2017
Third Pole Therapeutics, based in Waltham, Massachusetts, specializes in developing innovative, on-demand nitric oxide delivery systems for various medical applications. Their core technology generates pure, inhalable nitric oxide from air and electricity, eliminating the need for bulky gas cylinders. This system is equivalent to traditional tank-gas methods and has proven effective in treating hypoxic respiratory failure in newborns. The company aims to expand the accessibility of nitric oxide therapy, which is currently limited to certain countries and healthcare settings, to save lives and improve patient outcomes in conditions like malaria, heart attacks, and strokes.

Yieldstreet

Seed Round in 2016
Yieldstreet is a management platform that provides retail investors access to income-generating investment products. Founded in 2015, It gives individuals access to alternative investments that have traditionally been off-limits to the average investor. With over $2.5 billion invested across multiple asset classes, Yieldstreet is changing the way people generate passive income by lowering and removing the barriers that historically kept these lucrative opportunities far out of reach. In 2013, founders Milind Mehere and Michael Weisz were frustrated that many investment strategies were typically reserved only for institutions and the ultra-wealthy. Typically, the average investor was left to choose between the stock market and bonds with falling yields - with few options in between. Asset-based investments had longer hold periods and a higher barrier of entry, keeping them well out of reach of accredited investors — even more so for unaccredited investors. As a result, they decided to leverage the growing fintech disruption to give more people access to these previously restricted alternative investments. Milind’s background in building companies combined with Michael’s decade-plus experience in investing and fund management formed the core of Yieldstreet. Passion for their investors and employees as well as a willing embrace of innovation, has been part of Yieldstreet’s identity from the beginning. Each decision to leverage a new technology, or investment strategy, or originate a new deal is made to put investors first. That drive has propelled Yieldstreet across all 50 states, crossing $100M invested in less than eight quarters, with the $1B milestone coming only three years later. In 2019, Yieldstreet’s membership had grown to 100,000, and a savings account for members was launched. Yieldstreet, since its launch in 2015, has not deviated from its goal to change investing for the better, nor has it slowed down. Yieldstreet was ranked number 46 on the Inc. 5000 list of the fastest-growing companies and has been recognized by Built In as one of the Best Places to Work. Yieldstreet today delivers wealth generation options and alternative investments for more than 330,000 investors and has returned more than $1.3 billion in principal/interest. Many alternative investment platforms only focus on one asset class, such as real estate or art. Yieldstreet’s offerings, accessed through cash or a low-fee IRA, cover a wide range of asset classes — art, real estate, legal, corporates, consumer, and commercial, via single investments or funds. Yieldstreet also offers its members short-term notes on offerings with a hold period between 3 and 6 months, which generally boast higher interest rates than money markets and CDs. Yieldstreet is headquartered in New York and has offices in Brazil, Greece, and Malta. Michael Weisz serves as President and Milind Mehere serves as CEO. Together, they manage a team of more than 140 employees, all working toward Yieldstreet’s one goal: to change the way people invest for the better.

Trunomi

Seed Round in 2016
Trunomi, Inc. is a technology company that operates a consent-based data sharing platform aimed at enhancing customer verification processes for clients in the financial industry, both in the United States and internationally. Established in 2014 and headquartered in Campbell, California, Trunomi empowers consumers to digitally manage and share their personal data through a personal data store, while ensuring compliance with data privacy regulations. The platform offers features such as secure messaging, document sharing, and digital rights management, allowing businesses to visualize and manage customer data effectively. Trunomi's patented technology ensures that it does not store or access customer personal data, thereby transcending jurisdictional limitations associated with data privacy. Certified to meet NSA security standards and validated by legal experts, the platform provides a zero-risk solution for organizations to comply with global regulations, automate data subject requests, and enhance the overall customer experience related to privacy.

Yieldstreet

Seed Round in 2016
Yieldstreet is a management platform that provides retail investors access to income-generating investment products. Founded in 2015, It gives individuals access to alternative investments that have traditionally been off-limits to the average investor. With over $2.5 billion invested across multiple asset classes, Yieldstreet is changing the way people generate passive income by lowering and removing the barriers that historically kept these lucrative opportunities far out of reach. In 2013, founders Milind Mehere and Michael Weisz were frustrated that many investment strategies were typically reserved only for institutions and the ultra-wealthy. Typically, the average investor was left to choose between the stock market and bonds with falling yields - with few options in between. Asset-based investments had longer hold periods and a higher barrier of entry, keeping them well out of reach of accredited investors — even more so for unaccredited investors. As a result, they decided to leverage the growing fintech disruption to give more people access to these previously restricted alternative investments. Milind’s background in building companies combined with Michael’s decade-plus experience in investing and fund management formed the core of Yieldstreet. Passion for their investors and employees as well as a willing embrace of innovation, has been part of Yieldstreet’s identity from the beginning. Each decision to leverage a new technology, or investment strategy, or originate a new deal is made to put investors first. That drive has propelled Yieldstreet across all 50 states, crossing $100M invested in less than eight quarters, with the $1B milestone coming only three years later. In 2019, Yieldstreet’s membership had grown to 100,000, and a savings account for members was launched. Yieldstreet, since its launch in 2015, has not deviated from its goal to change investing for the better, nor has it slowed down. Yieldstreet was ranked number 46 on the Inc. 5000 list of the fastest-growing companies and has been recognized by Built In as one of the Best Places to Work. Yieldstreet today delivers wealth generation options and alternative investments for more than 330,000 investors and has returned more than $1.3 billion in principal/interest. Many alternative investment platforms only focus on one asset class, such as real estate or art. Yieldstreet’s offerings, accessed through cash or a low-fee IRA, cover a wide range of asset classes — art, real estate, legal, corporates, consumer, and commercial, via single investments or funds. Yieldstreet also offers its members short-term notes on offerings with a hold period between 3 and 6 months, which generally boast higher interest rates than money markets and CDs. Yieldstreet is headquartered in New York and has offices in Brazil, Greece, and Malta. Michael Weisz serves as President and Milind Mehere serves as CEO. Together, they manage a team of more than 140 employees, all working toward Yieldstreet’s one goal: to change the way people invest for the better.

Kaleo Software

Series A in 2015
Kaleo Software is a California-based company that specializes in creating an online platform designed to facilitate the exchange of knowledge within organizations. Established in 2011 and based in El Segundo, Kaleo Software enables users to connect with colleagues and subject matter experts to extract, contribute, and share information efficiently. The platform captures and tags data to build a dynamic knowledge base, allowing users to find answers to essential business questions through input from co-workers and topic experts. It integrates with popular business applications like SharePoint, ServiceNow, and Slack to deliver relevant information precisely when and where employees need it. Kaleo Software also provides powerful analytics to identify trending topics and locate experts within the organization.

Alignable

Venture Round in 2015
Alignable operates a global online network for small business owners, facilitating connections, referrals, and advice-sharing across over 30,000 local communities. Founded in Boston in 2014, the platform enables users to drive leads, generate referrals, and grow their businesses through trusted relationships.

Trunomi

Seed Round in 2015
Trunomi, Inc. is a technology company that operates a consent-based data sharing platform aimed at enhancing customer verification processes for clients in the financial industry, both in the United States and internationally. Established in 2014 and headquartered in Campbell, California, Trunomi empowers consumers to digitally manage and share their personal data through a personal data store, while ensuring compliance with data privacy regulations. The platform offers features such as secure messaging, document sharing, and digital rights management, allowing businesses to visualize and manage customer data effectively. Trunomi's patented technology ensures that it does not store or access customer personal data, thereby transcending jurisdictional limitations associated with data privacy. Certified to meet NSA security standards and validated by legal experts, the platform provides a zero-risk solution for organizations to comply with global regulations, automate data subject requests, and enhance the overall customer experience related to privacy.

Omaze

Series A in 2015
Omaze operates a unique online platform that combines fundraising for charitable initiatives with exciting prize experiences. It hosts auctions where donors can bid for chances to win once-in-a-lifetime opportunities such as celebrity encounters, luxury items, or exclusive travel packages. Omaze provides comprehensive services including marketing, content creation, technology support, and fulfillment to facilitate these experiences while raising funds for various causes.

EKCS

Venture Round in 2014
EKCS is an independent provider of creative production solutions across print, digital, video, and packaging. It combines cross-channel production expertise with clients’ creative vision to deliver compelling campaigns. The company offers pre-media, print and digital advertisement production, creative design, editorial services, website and application development, and video post-production, enabling brands to streamline media production and reduce costs with offshore delivery options. EKCS serves businesses seeking integrated production support across multiple media, delivering consistent quality and efficiency from concept through final output.

Omaze

Seed Round in 2014
Omaze operates a unique online platform that combines fundraising for charitable initiatives with exciting prize experiences. It hosts auctions where donors can bid for chances to win once-in-a-lifetime opportunities such as celebrity encounters, luxury items, or exclusive travel packages. Omaze provides comprehensive services including marketing, content creation, technology support, and fulfillment to facilitate these experiences while raising funds for various causes.

Alignable

Venture Round in 2014
Alignable operates a global online network for small business owners, facilitating connections, referrals, and advice-sharing across over 30,000 local communities. Founded in Boston in 2014, the platform enables users to drive leads, generate referrals, and grow their businesses through trusted relationships.

Think Through Learning

Series B in 2013
Think Through Learning's key product line, Think Through Math, is America's leading online math remediation software. There are almost 3,000,000 students in over 180,000 classrooms who are paid subscribers to Think Through Math. Think Through Math is a unique SaaS system integrating student motivation, instant on-demand interventions from state-certified US math teachers, and award winning adaptive math instruction that teaches students higher order thinking skills. Winner of the 2014 and 2012 CODiE for Best Math Instructional Solution, Think Through Math is proven to raise students understanding of math. Each student starts with an adaptive placement test that moves them right to the math they need to learn. Extensive guided feedback supports them. When they are stuck, a U.S., state-cerfiied, classroom experienced math teacher will pop up within 10 seconds to tutor them in real time. A January, 2015 independent research study commissioned by the Texas Education Agency (TEA) of 755,440 students who used Think Through Math showed that students using the system on a regular basis improved their math scores an average of 23%. The study is available of the TEA website. Numerous other studies have proven Think Through Math significantly improves students understanding of math.

Chirpify

Series A in 2013
Chirpify, Inc. is a social media loyalty platform based in Portland, Oregon, founded in 2011. The company provides engagement and loyalty solutions for marketers, enabling brands to transform mobile and social media interactions into rewards and foster brand loyalty. Chirpify's platform facilitates "in-stream" marketing and commerce, allowing consumers to engage directly with brands on social media, such as by commenting to initiate purchases. Its offerings include consumer engagement loyalty programs, campaign activation, marketing chatbots, employee advocacy programs, event activation, and customer insights. By creating a currency exchange between social media actions and loyalty programs, Chirpify enhances member acquisition, engagement, and customer lifetime value for businesses.

BiOWiSH Technologies

Venture Round in 2013
BiOWiSH Technologies develops and manufactures biotechnology products that enhance environmental management and agriculture. Its solutions include wastewater treatment, waste management, odor control, soil remediation, agronomy, and animal agriculture applications. Serving industries such as consumer goods, wastewater treatment, agriculture, aquaculture, and industrial cleaning, BiOWiSH's products are formulated for stability and distinct functionality across varied operating conditions.

Xpress Natural Gas

Venture Round in 2013
Xpress Natural Gas LLC is a Boston-based company founded in 2011 that specializes in the procurement and delivery of natural gas to customers who are not connected to traditional pipeline systems in the United States. The company focuses on providing compressed natural gas (CNG) and liquefied natural gas (LNG) to industrial and commercial clients, as well as municipalities that lack access to pipeline infrastructure. Xpress Natural Gas operates a production facility and distribution terminal in Manheim, New York, and is recognized as a pioneer in the "virtual pipeline" concept. By utilizing advanced technology and a network of compression stations and high-capacity trailers, the company aims to deliver cost-effective and sustainable energy solutions, helping clients significantly reduce operational costs compared to conventional fuels. Additionally, Xpress Natural Gas offers emergency services for utilities facing pipeline constraints, further enhancing its role in providing reliable energy options.

Knopp Biosciences

Series C in 2012
Knopp Biosciences LLC is a biotechnology company specializing in the discovery and development of innovative medicines for inflammatory and neurological diseases. Founded in 2004 and headquartered in Pittsburgh, Pennsylvania, the company focuses on addressing high-cost diseases with identifiable patient populations through validated biomarkers or genetic testing. Its clinical programs include dexpramipexole, an anti-inflammatory therapeutic aimed at modulating white blood cells, and a hematology discovery program targeting the selective arrest of eosinophil maturation for treating inflammatory conditions. Additionally, Knopp Biosciences is advancing a preclinical program aimed at activating the KCNQ2 ion channel, which is linked to neonatal encephalopathy, epilepsy, and neuropathic pain, as well as a mitochondrial discovery program that seeks to enhance mitochondrial efficiency through small molecule modulators. The company's mission is to accelerate treatment advancements, change disease trajectories, and improve patient outcomes.

Think Through Learning

Series B in 2011
Think Through Learning's key product line, Think Through Math, is America's leading online math remediation software. There are almost 3,000,000 students in over 180,000 classrooms who are paid subscribers to Think Through Math. Think Through Math is a unique SaaS system integrating student motivation, instant on-demand interventions from state-certified US math teachers, and award winning adaptive math instruction that teaches students higher order thinking skills. Winner of the 2014 and 2012 CODiE for Best Math Instructional Solution, Think Through Math is proven to raise students understanding of math. Each student starts with an adaptive placement test that moves them right to the math they need to learn. Extensive guided feedback supports them. When they are stuck, a U.S., state-cerfiied, classroom experienced math teacher will pop up within 10 seconds to tutor them in real time. A January, 2015 independent research study commissioned by the Texas Education Agency (TEA) of 755,440 students who used Think Through Math showed that students using the system on a regular basis improved their math scores an average of 23%. The study is available of the TEA website. Numerous other studies have proven Think Through Math significantly improves students understanding of math.

Panopto

Venture Round in 2010
Panopto, Inc. is a video software company that provides a comprehensive platform for video content management tailored for corporate and educational markets globally. Founded in 2007 and headquartered in Seattle, Washington, with additional offices in cities such as Pittsburgh, London, Sydney, and Hong Kong, Panopto specializes in creating searchable video libraries that preserve institutional knowledge. The platform encompasses a variety of functionalities, including video streaming, analytics, accessibility features, and live broadcasting capabilities. It supports users in recording and editing videos, facilitating employee training, onboarding, and live events for enterprises, as well as enhancing educational experiences through lecture capture and active learning. Panopto has established itself as a leader in video capture software and content management systems, recognized for its innovation and rapid growth within the industry.

Knopp Biosciences

Series B in 2008
Knopp Biosciences LLC is a biotechnology company specializing in the discovery and development of innovative medicines for inflammatory and neurological diseases. Founded in 2004 and headquartered in Pittsburgh, Pennsylvania, the company focuses on addressing high-cost diseases with identifiable patient populations through validated biomarkers or genetic testing. Its clinical programs include dexpramipexole, an anti-inflammatory therapeutic aimed at modulating white blood cells, and a hematology discovery program targeting the selective arrest of eosinophil maturation for treating inflammatory conditions. Additionally, Knopp Biosciences is advancing a preclinical program aimed at activating the KCNQ2 ion channel, which is linked to neonatal encephalopathy, epilepsy, and neuropathic pain, as well as a mitochondrial discovery program that seeks to enhance mitochondrial efficiency through small molecule modulators. The company's mission is to accelerate treatment advancements, change disease trajectories, and improve patient outcomes.

Knopp Biosciences

Series A in 2006
Knopp Biosciences LLC is a biotechnology company specializing in the discovery and development of innovative medicines for inflammatory and neurological diseases. Founded in 2004 and headquartered in Pittsburgh, Pennsylvania, the company focuses on addressing high-cost diseases with identifiable patient populations through validated biomarkers or genetic testing. Its clinical programs include dexpramipexole, an anti-inflammatory therapeutic aimed at modulating white blood cells, and a hematology discovery program targeting the selective arrest of eosinophil maturation for treating inflammatory conditions. Additionally, Knopp Biosciences is advancing a preclinical program aimed at activating the KCNQ2 ion channel, which is linked to neonatal encephalopathy, epilepsy, and neuropathic pain, as well as a mitochondrial discovery program that seeks to enhance mitochondrial efficiency through small molecule modulators. The company's mission is to accelerate treatment advancements, change disease trajectories, and improve patient outcomes.

ReefEdge

Venture Round in 2003
ReefEdge Inc., established in Spring 2000, specializes in wireless local area network (WLAN) systems tailored for multi-site enterprises. The company develops technologies to facilitate secure, reliable, and managed connectivity for mobile devices equipped with short-range wireless capabilities like Bluetooth. ReefEdge's products enable the deployment of innovative, location-aware mobile applications within corporate networking environments. Led by a seasoned executive team with extensive experience delivering enterprise solutions, previously from companies such as IBM, AT&T, Telcordia, and Prodigy, ReefEdge focuses on providing secure wireless network infrastructure products that ensure mobility and session persistence while offering robust management capabilities for WLANs.

BodyMedia

Series C in 2003
BodyMedia, founded in 1999 and based in Pittsburgh, Pennsylvania, specializes in the development of wearable body monitoring devices that collect physiological data to enhance health, wellness, and fitness. The company offers a range of continuous on-body monitors that utilize proprietary technology, clinically validated for accuracy. BodyMedia's devices assist both consumers and health professionals in making informed behavioral changes to manage weight and promote an active lifestyle, which are critical in addressing various medical conditions. The company has developed one of the largest databases of human physiological information, with its technology being utilized in over 100 clinical research studies related to health issues such as obesity, diabetes, and sleep disorders. Additionally, BodyMedia provides metabolic assessment and behavioral therapy services aimed at treating obesity and cardiovascular diseases, along with calorie management systems that help users track and compare calories burned with those consumed.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.